STATEMENT OF NEED

Cancer remains one of the leading causes of morbidity and mortality worldwide, with ongoing advancements in diagnostics, molecular profiling, and therapeutics shaping the future of patient care. The rapid evolution of targeted therapies, immune-based treatments, and personalized medicine has created a critical need for healthcare professionals to stay informed about emerging clinical trial data and best practices in oncology management.

This Visiting Faculty Series, led by renowned oncology experts, will explore the latest breakthroughs in cancer research, including biomarker-driven treatment selection, novel therapeutic combinations, and strategies for mitigating adverse effects. Participants will gain expert perspectives on integrating these advancements into clinical workflows to improve survival and quality of life for patients across various tumor types.

TARGET AUDIENCE

Medical oncologists, radiation oncologists, surgical oncologists, hematologists, pathologists, nurse practitioners, physician assistants, oncology nurses, pharmacists, and other healthcare professionals involved in the diagnosis, treatment, and management of patients with cancer.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

• Evaluate emerging biomarkers and genomic profiling techniques to guide personalized cancer treatment
• Assess the latest clinical trial data on novel targeted therapies, immunotherapies, and combination regimens
• Apply best practices for managing adverse events and optimizing patient outcomes in oncology care
• Integrate multidisciplinary approaches to improve cancer care delivery and enhance patient-centered treatment strategies

This oncology-focused educational series is designed to provide actionable insights that will support clinicians in navigating the complexities of modern cancer treatment.